Literature DB >> 31897659

Lung cancer-derived extracellular vesicles: a possible mediator of mast cell activation in the tumor microenvironment.

Pazit Salamon1, Yoseph A Mekori1,2,3, Irit Shefler4.   

Abstract

Activated mast cells are often found in the tumor microenvironment. They have both pro- and anti-tumorigenic roles, depending on the tumor type. Several lines of evidence suggest that the tumor microenvironment contains multiple soluble factors that can drive mast cell recruitment and activation. However, it is not yet clear how mast cells are activated by tumor cells. In this study, we explored whether tumor-derived microvesicles (TMV) from non-small cell lung cancer (NSCLC) cells interact with human mast cells, activate them to release cytokines, and affect their migratory ability. PKH67-labelled TMV isolated from NSCLC cell lines were found to be internalized by mast cells. This internalization was first noticed after 4 h and peaked within 24 h of co-incubation. Furthermore, internalization of TMV derived from NSCLC cell lines or from surgical lung tissue specimens resulted in ERK phosphorylation, enhanced mast cell migratory ability and increased release of cytokines and chemokines, such as TNF-α and MCP-1. Our data are thus, consistent with the conclusion that TMV have the potential to influence mast cell activity and thereby, affect tumorigenesis.

Entities:  

Keywords:  Extracellular vesicles; Lung tumor; Mast cell; Microvesicles

Mesh:

Year:  2020        PMID: 31897659     DOI: 10.1007/s00262-019-02459-w

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  9 in total

1.  Construction of a prognostic model for non-small-cell lung cancer based on ferroptosis-related genes.

Authors:  Ke Han; Jukun Wang; Kun Qian; Teng Zhao; Xingsheng Liu; Yi Zhang
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

Review 2.  Extracellular vesicles in immunomodulation and tumor progression.

Authors:  Carolyn Marar; Bartholomew Starich; Denis Wirtz
Journal:  Nat Immunol       Date:  2021-03-22       Impact factor: 31.250

3.  IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors.

Authors:  Leonardo Cristinziano; Remo Poto; Gjada Criscuolo; Anne Lise Ferrara; Maria Rosaria Galdiero; Luca Modestino; Stefania Loffredo; Amato de Paulis; Gianni Marone; Giuseppe Spadaro; Gilda Varricchi
Journal:  Cells       Date:  2021-01-12       Impact factor: 6.600

Review 4.  Mast Cells as Important Regulators in Autoimmunity and Cancer Development.

Authors:  Christine N Noto; Stella G Hoft; Richard J DiPaolo
Journal:  Front Cell Dev Biol       Date:  2021-10-12

5.  Tumor-Derived Extracellular Vesicles Induce CCL18 Production by Mast Cells: A Possible Link to Angiogenesis.

Authors:  Irit Shefler; Pazit Salamon; Tali Zitman-Gal; Yoseph A Mekori
Journal:  Cells       Date:  2022-01-21       Impact factor: 6.600

6.  Construction of a redox-related gene signature for overall survival prediction and immune infiltration in non-small-cell lung cancer.

Authors:  Ti-Wei Miao; De-Qing Yang; Li-Juan Gao; Jie Yin; Qi Zhu; Jie Liu; Yan-Qiu He; Xin Chen
Journal:  Front Mol Biosci       Date:  2022-08-16

7.  CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.

Authors:  Jianlong Tan; Fengyu Chen; Bin Ouyang; Xiuying Li; Weidong Zhang; Xinglin Gao
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

Review 8.  Signal Transduction Pathways Activated by Innate Immunity in Mast Cells: Translating Sensing of Changes into Specific Responses.

Authors:  Zyanya P Espinosa-Riquer; Deisy Segura-Villalobos; Itzel G Ramírez-Moreno; Marian Jesabel Pérez Rodríguez; Mónica Lamas; Claudia Gonzalez-Espinosa
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

Review 9.  Role of Cytokines and Chemokines in NSCLC Immune Navigation and Proliferation.

Authors:  Sowmya Ramachandran; Amit K Verma; Kapil Dev; Yamini Goyal; Deepti Bhatt; Mohammed A Alsahli; Arshad Husain Rahmani; Ahmad Almatroudi; Saleh A Almatroodi; Faris Alrumaihi; Naushad Ahmad Khan
Journal:  Oxid Med Cell Longev       Date:  2021-07-16       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.